Alamar Biosciences
PrivateLast Round
IPO Announced
Apr 20, 2026
Est. Valuation
$1.1B
Total Funding Raised
$348.32M
Momentum Score
25 /100
Company Overview
Alamar Biosciences is a biotechnology company that develops a precision proteomics platform for protein analysis and cancer detection, utilizing advanced antibody technologies to enhance disease diagnosis and facilitate early biomarker discovery for improved patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alamar Biosciences Comps
Public and private peers based on sector, stage, and business model.
Alamar Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Apr 20, 2026 | ||||
| Convertible Debt | Jan 11, 2026 | ||||
| Convertible Debt | Jan 11, 2026 | ||||
| Grant | Jan 8, 2025 | ||||
| Series C | Feb 26, 2024 | ||||
Series B | Sep 8, 2021 |
Key People
Founding team and executive leadership
Alamar Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Braidwell | Convertible Debt |
| Gates Ventures | Grant |
| Morningside Ventures | Series B |
| ARCH Venture Partners | Series C |
| T. Rowe Price | Convertible Debt |
| Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator | Grant |
| TMCP | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Reported $74.2M in revenue for fiscal year 2025.
- Apr 24, 2026
Reported $25.1 million in revenue for fiscal year 2024.
Alamar Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alamar Biosciences's valuation, stock price, and market status.
